Is RGC or USNA more undervalued in 2026?

CirclFi compares Regencell Bioscience Holdings L (RGC) and USANA Health Sciences, Inc. (USNA) using 13 institutional-grade valuation models. RGC has a Quality of Company score of 4.6/10 while USNA scores 7.8/10.

Which is a better buy — RGC or USNA?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do RGC and USNA valuations compare?

RGC at $23.90 and USNA at $18.30 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

RGC vs USNA Valuation Comparison 2026 — Intrinsic Value Analysis

RGC

Medicinal Chemicals & Botanical Products

Regencell Bioscience Holdings L

Quality

4.6

out of 10

Value Trap

SAFE

Price

$23.90

Last close

Models

10/13

Active

USNA

Medicinal Chemicals & Botanical Products

USANA Health Sciences, Inc.

Quality

7.8

out of 10

Value Trap

LOW

Price

$18.30

Last close

Models

13/13

Active

Model-by-Model Comparison

Model	Type	RGC Fair Value	RGC Upside	USNA Fair Value	USNA Upside
Bayesian DCF	Intrinsic	$9.12	-61.8%	$37.21	+103.3%
Earnings Power Value	Intrinsic	$11.09	-59.7%	$16.19	-11.5%
EROIC Spread	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
Markov DDM	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$•••.••	••.•%	$•••.••	••.•%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$•••.••	••.•%	$•••.••	••.•%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%
FTNN Topology	Relative	$•••.••	••.•%	$•••.••	••.•%
RCMH-DCF	Intrinsic	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for RGC vs USNA — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

RGC vs USNA — Which Stock Is More Undervalued?

USNA scores higher with a 7.8/10 quality rating vs RGC's 4.6/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Regencell Bioscience Holdings L (RGC) and USANA Health Sciences, Inc. (USNA) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

RGC currently trades at $23.90 with a QOC of 4.6/10, while USNA trades at $18.30 with a QOC of 7.8/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).